217 related articles for article (PubMed ID: 15004510)
1. Possible apoptotic mechanism in epidermal cell acantholysis induced by pemphigus vulgaris autoimmunoglobulins.
Wang X; Brégégère F; Frusić-Zlotkin M; Feinmesser M; Michel B; Milner Y
Apoptosis; 2004 Mar; 9(2):131-43. PubMed ID: 15004510
[TBL] [Abstract][Full Text] [Related]
2. The interaction of pemphigus autoimmunoglobulins with epidermal cells: activation of the fas apoptotic pathway and the use of caspase activity for pathogenicity tests of pemphigus patients.
Frusic-Zlotkin M; Pergamentz R; Michel B; David M; Mimouni D; Brégégère F; Milner Y
Ann N Y Acad Sci; 2005 Jun; 1050():371-9. PubMed ID: 16014554
[TBL] [Abstract][Full Text] [Related]
3. Apoptotic mechanism in pemphigus autoimmunoglobulins-induced acantholysis--possible involvement of the EGF receptor.
Frusić-Zlotkin M; Raichenberg D; Wang X; David M; Michel B; Milner Y
Autoimmunity; 2006 Nov; 39(7):563-75. PubMed ID: 17101500
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis in pemphigus.
Schmidt E; Waschke J
Autoimmun Rev; 2009 Jun; 8(7):533-7. PubMed ID: 19189866
[TBL] [Abstract][Full Text] [Related]
5. Replicative senescence enhances apoptosis induced by pemphigus autoimmune antibodies in human keratinocytes.
Wang X; Brégégère F; Soroka Y; Frusic-Zlotkin M; Milner Y
FEBS Lett; 2004 Jun; 567(2-3):281-6. PubMed ID: 15178337
[TBL] [Abstract][Full Text] [Related]
6. Pemphigus vulgaris autoantibodies induce apoptosis in HaCaT keratinocytes.
Pelacho B; Natal C; España A; Sánchez-Carpintero I; Iraburu MJ; López-Zabalza MJ
FEBS Lett; 2004 May; 566(1-3):6-10. PubMed ID: 15147859
[TBL] [Abstract][Full Text] [Related]
7. The pathogenic role of autoantibodies in pemphigus vulgaris.
Pan M; Liu X; Zheng J
Clin Exp Dermatol; 2011 Oct; 36(7):703-7. PubMed ID: 21906124
[TBL] [Abstract][Full Text] [Related]
8. Synergistic actions of pemphigus vulgaris IgG, Fas-ligand and tumor necrosis factor-alpha during induction of basal cell shrinkage and acantholysis.
Orlov MD; Chernyavsky AI; Arredondo J; Grando SA
Autoimmunity; 2006 Nov; 39(7):557-62. PubMed ID: 17101499
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis is not required for acantholysis in pemphigus vulgaris.
Schmidt E; Gutberlet J; Siegmund D; Berg D; Wajant H; Waschke J
Am J Physiol Cell Physiol; 2009 Jan; 296(1):C162-72. PubMed ID: 18987254
[TBL] [Abstract][Full Text] [Related]
10. Apoptolysis: a novel mechanism of skin blistering in pemphigus vulgaris linking the apoptotic pathways to basal cell shrinkage and suprabasal acantholysis.
Grando SA; Bystryn JC; Chernyavsky AI; Frusić-Zlotkin M; Gniadecki R; Lotti R; Milner Y; Pittelkow MR; Pincelli C
Exp Dermatol; 2009 Sep; 18(9):764-70. PubMed ID: 19555352
[TBL] [Abstract][Full Text] [Related]
11. High-dose pemphigus antibodies against linear epitopes of desmoglein 3 (Dsg3) can induce acantholysis and depletion of Dsg3 from keratinocytes.
Cirillo N; Femiano F; Gombos F; Lanza A
Immunol Lett; 2009 Feb; 122(2):208-13. PubMed ID: 19200441
[TBL] [Abstract][Full Text] [Related]
12. If pemphigus vulgaris IgG are the cause of acantholysis, new IgG-independent mechanisms are the concause.
Cirillo N; Lanza M; Femiano F; Gaeta GM; De Rosa A; Gombos F; Lanza A
J Cell Physiol; 2007 Sep; 212(3):563-7. PubMed ID: 17474087
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of FAK prevents blister formation in the neonatal mouse model of pemphigus vulgaris.
Gil MP; Modol T; España A; López-Zabalza MJ
Exp Dermatol; 2012 Apr; 21(4):254-9. PubMed ID: 22320676
[TBL] [Abstract][Full Text] [Related]
14. Pemphigus vulgaris: recent advances in our understanding of its pathogenesis.
Femiano F
Minerva Stomatol; 2007 Apr; 56(4):215-23. PubMed ID: 17452959
[TBL] [Abstract][Full Text] [Related]
15. Changes in desmoglein 1 expression and subcellular localization in cultured keratinocytes subjected to anti-desmoglein 1 pemphigus autoimmunity.
Cirillo N; Gombos F; Lanza A
J Cell Physiol; 2007 Feb; 210(2):411-6. PubMed ID: 17058228
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone inhibits plasminogen activator activity in experimental pemphigus in vivo but does not block acantholysis.
Anhalt GJ; Patel HP; Labib RS; Diaz LA; Proud D
J Immunol; 1986 Jan; 136(1):113-7. PubMed ID: 3079604
[TBL] [Abstract][Full Text] [Related]
17. Novel mechanisms of target cell death and survival and of therapeutic action of IVIg in Pemphigus.
Arredondo J; Chernyavsky AI; Karaouni A; Grando SA
Am J Pathol; 2005 Dec; 167(6):1531-44. PubMed ID: 16314468
[TBL] [Abstract][Full Text] [Related]
18. Intraperitoneal injection of pemphigus vulgaris-IgG into mouse depletes epidermal keratinocytes of desmoglein 3 associated with generation of acantholysis.
Shu E; Yamamoto Y; Aoyama Y; Kitajima Y
Arch Dermatol Res; 2007 Jun; 299(3):165-7. PubMed ID: 17431647
[TBL] [Abstract][Full Text] [Related]
19. The final destiny of acantholytic cells in pemphigus is Fas mediated.
Pacheco-Tovar MG; Avalos-Díaz E; Vega-Memije E; Bollain-y-Goytia JJ; López-Robles E; Hojyo-Tomoka MT; Domínguez-Soto L; Herrera-Esparza R
J Eur Acad Dermatol Venereol; 2009 Jun; 23(6):697-701. PubMed ID: 19470049
[TBL] [Abstract][Full Text] [Related]
20. IgG autoantibodies directed against desmoglein 3 cause dissociation of keratinocytes in canine pemphigus vulgaris and paraneoplastic pemphigus.
Nishifuji K; Olivry T; Ishii K; Iwasaki T; Amagai M
Vet Immunol Immunopathol; 2007 Jun; 117(3-4):209-21. PubMed ID: 17350107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
